|
|
Volumn 26, Issue 2, 1996, Pages 243-244
|
|
Does activated protein C resistance increase the risk of systemic embolism in non rheumatic atrial fibrillation?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMIODARONE;
BLOOD CLOTTING FACTOR 5;
CARDIOLIPIN ANTIBODY;
HEPARIN;
PROTEIN C;
SOTALOL;
WARFARIN;
AGED;
ARTICLE;
BLEEDING;
CASE REPORT;
CLINICAL TRIAL;
EMBOLISM;
HEART ATRIUM FIBRILLATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
ORAL DRUG ADMINISTRATION;
RISK FACTOR;
VEIN THROMBOSIS;
|
|
EID: 0029900164
PISSN: 00048291
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1445-5994.1996.tb00899.x Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
